| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.009 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |